Ramazan Jabbarli

Prof. Dr. Ramazan Jabbarli

Department of Neurosurgery & Spine Surgery, University Hospital Essen, 45147 Essen, Germany
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RRRoland Roelz
Roland Roelz
DSDavid Strohmaier
David Strohmaier
RJRamazan Jabbarli
Ramazan Jabbarli
RKRainer Kraeutle
Rainer Kraeutle
KEKarl Egger
Karl Egger
PRPeter C. Reinacher
Peter C. Reinacher
Diffuse low grade gliomas (DLGG) are continuously progressive primary brain neoplasms that lead to neurological deficits and death. Treatment strategies are controversial. Randomized trials establishing the prognostic value of surgery do not exist. Here, we report the results of a nine-year near-randomized patient distribution between resection and biopsy. Until 2012, the Department of Neurosurgery and the Department of Stereotactic Neurosurgery at the University Medical Center Freiburg were organized as separate administrative units both coordinating DLGG patient treatment independently. All consecutive adult patients with a new diagnosis of DLGG by either stereotactic biopsy or resection were included. Pre- and post-operative tumor volumetry was performed. 126 patients, 87 men (69%), 39 women (31%), median age 41 years, were included. 77 (61%) were initially managed by biopsy, 49 (39%) by resection. A significant survival benefit was found for patients with an initial management by resection (5-year OS 82% vs. 54%). The survival benefit of patients with initial resection was reserved to patients with a residual tumor volume of less than 15 cm3. Maximum safe resection is the first therapy of choice in DLGG patients if a near-complete tumor removal can be achieved. Accurate prediction of the extent-of-resection is required for selection of surgical candidates.

30 July 2019 in Neurology
Verified
Journal Article
Closed access
PDF file
RJRamazan Jabbarli
Ramazan Jabbarli
DPDaniela Pierscianek
Daniela Pierscianek
RRRoland Rölz
Roland Rölz
MOMarvin Darkwah Oppong
Marvin Darkwah Oppong
KKKlaus Kaier
Klaus Kaier
MFMichael Forsting
Michael Forsting
Objective Delayed cerebral ischemia (DCI) is strongly associated with poor outcome after subarachnoid hemorrhage (SAH). Cerebral vasospasm is a major contributor to DCI and requires special attention. To evaluate the effect of vasospasm management on SAH outcome, we performed a pooled analysis of 2 observational SAH cohorts. Materials Data from 2 institutional databases with consecutive patients with SAH treated between 2005 and 2012 were pooled. The effect of 2 institutional standards of conservative and endovascular vasospasm treatment (EVT) on the rates of DCI (new cerebral infarcts not visible on the post-treatment imaging) and unfavorable outcome (modified Rankin Scale score >2) at 6 months follow-up was analyzed. Results The final analysis included 1,057 patients with SAH. There was no difference regarding demographic (age and sex), clinical (Hunt & Hess grades, acute hydrocephalus, treatment modality, and infections), and radiographic (Fisher grades and aneurysm location) characteristics of the populations. However, there was a significant difference in the rate (24.4% [121/495] vs 14.4% [81/562], p < 0.0001) and timing (first treatment on day 6 vs 8.9 after SAH, p < 0.0001) of EVT. The rates of DCI (20.8% vs 29%, p = 0.0001) and unfavorable outcome (44% vs 50.6%, p = 0.04) were lower in the cohort with more frequent and early EVT. Multivariate analysis confirmed independent effect of EVT standard on DCI risk and outcome. Conclusions A preventive strategy utilizing frequent and early EVT seems to reduce the risk of DCI in SAH patients and improve their functional outcome. We recommend prospective evaluation of the value of preventive EVT strategy on SAH. Classification of evidence This study provides Class III evidence that for patients with SAH, a frequent and early EVT to treat vasospasm reduces the risk of DCI and improves functional outcome.

1 April 2018 in Stroke
Verified
Journal Article
Closed access
RJRamazan Jabbarli
Ramazan Jabbarli
TDThiemo Florin Dinger
Thiemo Florin Dinger
MOMarvin Darkwah Oppong
Marvin Darkwah Oppong
DPDaniela Pierscianek
Daniela Pierscianek
PDPhilipp Dammann
Philipp Dammann
USUlrich Sure
Ulrich Sure
Background and Purpose—: Multiple intracranial aneurysms (MIAs) are common findings of cerebral angiographies; however, MIA prevalence varies in different patient cohorts. We sought to elucidate risk factors influencing MIA prevalence and the clinical consequences. Methods—: We systematically searched PubMed, Scopus, Embase, and Cochrane Library databases for publications before January 15, 2017, reporting MIA prevalence and risk factors. We used random-effects meta-analysis and multivariate regression analysis to assess the impacts of individual, study, and population characteristics. Results—: We included 174 studies reporting on MIA (mean overall prevalence, 20.1%; range, 2%–44.9%) in 134 study populations with 86 989 intracranial aneurysm (IA) patients enrolled between 1950 and 2015. Studies from Europe and North America ( P 40 years; OR, 1.6; 95% CI, 1.14–2.25), arterial hypertension (OR, 1.51; 95% CI, 1.17–1.94), smoking (OR, 1.89; 95% CI, 1.37–2.6) and familial IA (OR, 2.02; 95% CI, 1.47–2.77), and formation of de novo (OR, 3.92; 95% CI, 1.95–7.87) and growth of initial IA (OR, 3.47; 95% CI, 1.87–6.45). Risk of subarachnoid hemorrhage in MIA patients was higher only in longitudinal studies from Japan and Korea (OR, 2.08; 95% CI, 1.46–2.96). Conclusions—: Female sex, higher age, arterial hypertension, smoking, and familial IA are major risk factors for MIA. In addition, MIA patients are at risk for enhanced IA formation. Further studies are needed to evaluate rupture risk and the role of ethnicity, especially in the context of increased MIA identification with improved neurovascular imaging.

26 February 2016 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
RJRamazan Jabbarli
Ramazan Jabbarli
ABA.‐M. Bohrer
A.‐M. Bohrer
DPD. Pierscianek
D. Pierscianek
DMD. Müller
D. Müller
KWKarsten Henning Wrede
Karsten Henning Wrede
OMO. Müller
O. Müller

1 November 2016 in Journal of Neurosurgery
Verified
Journal Article
Closed access
RJRamazan Jabbarli
Ramazan Jabbarli
DPDaniela Pierscianek
Daniela Pierscianek
KWKarsten Wrede
Karsten Wrede
PDPhilipp Dammann
Philipp Dammann
MSMarc Schlamann
Marc Schlamann
USUlrich Sure
Ulrich Sure
OBJECTIVE: The complete clipping of a cerebral aneurysm usually warrants its sustained occlusion, while clip remnants may have far-reaching consequences. The aim of this study is to identify the risk factors for clip remnants requiring retreatment and/or exhibiting growth. METHODS: All consecutive patients with primary aneurysm clipping performed at University Hospital of Essen between January 1, 2003, and December 31, 2013, were eligible for this study. Aneurysm occlusion was judged on obligatory postoperative digital subtraction angiography and the need for repeated vascular control. The identified clip remnants were correlated with various demographic and clinical characteristics of the patients, aneurysm features, and surgery-related aspects. RESULTS: Of 616 primarily clipped aneurysms, postoperative angiography revealed 112 aneurysms (18%) with clip remnants requiring further control (n = 91) or direct retreatment (n = 21). Seven remnants exhibited growth during follow-up, whereas 2 cases were associated with aneurysmal bleeding. Therefore, a total of 28 aneurysms (4.5%) were retreated as clip remnants (range 1 day to 67 months after clipping). In the multivariate analysis, the need for retreatment of clip remnant was correlated with the aneurysm's initial size (> 12 mm; OR 3.22; p = 0.035) and location (anterior cerebral artery > internal carotid artery > posterior circulation > middle cerebral artery; OR 1.85; p = 0.003). Younger age with a cutoff at 45 years (OR 33.31; p = 0.004) was the only independent predictor for remnant growth. CONCLUSIONS: The size and location of the aneurysm are the main risk factors for clip remnants requiring retreatment. Because of the risk for growth, younger individuals (< 45 years old) with clip remnants require a long-term (> 5 years) vascular follow-up. Clinical trial registration no: DRKS00008749 (Deutsches Register Klinischer Studien)

13 December 2018 in Neurosurgery
Verified
Journal Article
Closed access
MOMarvin Darkwah Oppong
Marvin Darkwah Oppong
OGOliver Gembruch
Oliver Gembruch
DPDaniela Pierscianek
Daniela Pierscianek
MKMartin Köhrmann
Martin Köhrmann
Christoph KleinschnitzChristoph Kleinschnitz
Christoph Kleinschnitz
RJRamazan Jabbarli
Ramazan Jabbarli
BACKGROUND: Delayed cerebral ischemia (DCI) has a strong impact on outcome of patients with aneurysmal subarachnoid hemorrhage (SAH). Positive effect of antiplatelet therapy on DCI rates has been supposed upon smaller SAH series. OBJECTIVE: To analyze the benefit/risk profile of antiplatelet use in SAH patients. METHODS: This retrospective case–control study was based on institutional observational cohort with 994 SAH patients treated between January 2003 and June 2016. The individuals with postcoiling antiplatelet therapy (aspirin with/without clopidogrel) were compared to a control group without antiplatelet therapy. Occurrence of DCI, major/minor bleeding events in the follow-up computed tomography scans, and favorable outcome at 6 mo after SAH (modified Rankin scale < 3) were compared in both groups. RESULTS: Of 580 patients in the final analysis, 329 patients received post-treatment antiplatelet medication. There were no significant differences between the compared groups with regard to basic outcome confounders. Aspirin use was independently associated with reduced DCI risk (P < .001, adjusted odds ratio = 0.41, 95% confidence interval 0.24-0.65) and favorable outcome (P = .02, adjusted odds ratio = 1.78, 95% confidence interval 1.06-2.98). Regarding bleeding complications, aspirin was associated only with minor bleeding events (P = .02 vs P = .51 for major bleeding events). CONCLUSION: Regular administration of aspirin might have a positive impact on DCI risk and outcome of SAH patients, without increasing the risk for clinically relevant bleeding events. In our SAH cohort, dual antiplatelet therapy showed no additional benefit on DCI risk, but increased the likelihood of major bleeding events.